Iproteos opens EUR 1.5m funding round
Iproteos abre una ronda de financiación de EUR 1,5m
Intel ID : 238693
| Synopsis |
|
Iproteos, a Spain-based company engaged in research and development of new therapeutic strategies, opened a EUR 1.5m funding round to enter the pre-clinical phase of its IPR19 drug, reported Web Capital Riesgo on 14 July 2016. Of that sum, EUR 1m may come from Spain-based private equity firm Caixa Capital Risc (Global). Meanwhile, Iproteos launched a call through crowdfunding platform Capital Cell, with which it expects to fetch EUR 0.3m and which will also feature the participation of Spain-based group 1nkemia (MAB:IKM). The company also expects to fetch another EUR 0.2m of public financing.
(content in spanish)
Iproteos, empresa de I+D de nuevas estrategias terapeúticas, ha abierto una ronda de financiación de EUR 1,5m para la entrada en la fase preclínica de su fármaco IPR19, según ha reportado Web Capital Riesgo el 14 de julio de 2016. De esa cantidad, EUR 1m podría proceder de la entidad de private equity española Caixa Capital Risc (Global). Por otro lado, Iproteos ha llevado a cabo un llamamiento a través de la plataforma de crowdfunding Capital Cell, con la que espera captar EUR 0,3m y en la que también participará el grupo español 1nkemia (MAB: IKM). También espera captar otros EUR 0,2m de financiación pública. |
| Intel ID | 238693 | |||
| Value | EUR 1,50m (Approx.) | |||
| Native Currency | Euro (EUR) | |||
|
Financial Data - Iproteos
(31 Dec 2018) |
Revenue: EUR 1,47m Net Debt: EUR 5,67m People: 9 |
|||
| Date |
 |
|||
| Country |  |
|||
| Region | ||||
| Continent | |
|||
| Geography | |
|||
| Subsector (Old TTR Sectors) |
|
|||
| Type |
|
|||
| Intel Grade |
|
|||
| Source |
|
|||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
10.01.01 BPO/Outsource Services 10 Business Services / 10.01 Business & Professional Support Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.10 Venture Capital 25 Financial Services / 25.01 Banking & Investment |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Mergers & Acquisitions
| Date | Target | Country | Buyer | Seller | VALUE (EURm) | Subsector | |||
|
|
|
|
|
- |
|
|
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.